Geneva: World Health Organization It says the number of coronavirus cases worldwide has dropped by 17 percent over the past week, including a 50 percent drop from the previous week. United States of americaWhereas globally there has been a 7 percent drop in deaths.
The weekly epidemiological report of the United Nations Health Agency, released late Tuesday, shows that omicron The variant is increasingly taking effect – accounting for about 97 percent of all cases linked to the international virus-tracking platform known as GISAID. Only over 3 per cent belonged to the Delta variant.
“The prevalence of the Omicron variant has increased globally and is now detected in almost all countries,” the WHO said.
“While many countries have reported an initial increase in the number of cases due to the Omicron variant, there has now been a decline in the total number of new cases since the beginning of January 2022.”
All told, the WHO reported more than 19 million new cases of COVID-19 and less than 68,000 new deaths during the week from January 31 to February 6. Experts say such figures greatly underestimate the real toll.
There has been a decline in the number of cases in each of the WHO’s six regions, except for the eastern regions of the WHO interior region, which registered a growth of 36 per cent, with growth especially in Afghanistan, Iran and Jordan,
In Europe, the number of cases fell by 7 percent – due to a drop in places such as France and Germany – even as countries in Eastern Europe such as Azerbaijan, Belarus and Russia The post increases. In Of AmericaThe case count fell 36 percent, with the United States – still the worst-affected country – reporting 1.87 million new cases, down 50 percent from the previous week.
The WHO cited limited data about the effectiveness of vaccines against omicron variants, while estimates showed the safety of the first series of COVID-19 vaccines against the variants for severe disease, symptomatic disease and infection to be low. Vaccines were most effective at preventing severe disease from Omicron.
The agency said the booster dose raises estimates of vaccine effectiveness by more than 75 percent for all vaccines for which data is available, although rates drop three to six months after injection.
The weekly epidemiological report of the United Nations Health Agency, released late Tuesday, shows that omicron The variant is increasingly taking effect – accounting for about 97 percent of all cases linked to the international virus-tracking platform known as GISAID. Only over 3 per cent belonged to the Delta variant.
“The prevalence of the Omicron variant has increased globally and is now detected in almost all countries,” the WHO said.
“While many countries have reported an initial increase in the number of cases due to the Omicron variant, there has now been a decline in the total number of new cases since the beginning of January 2022.”
All told, the WHO reported more than 19 million new cases of COVID-19 and less than 68,000 new deaths during the week from January 31 to February 6. Experts say such figures greatly underestimate the real toll.
There has been a decline in the number of cases in each of the WHO’s six regions, except for the eastern regions of the WHO interior region, which registered a growth of 36 per cent, with growth especially in Afghanistan, Iran and Jordan,
In Europe, the number of cases fell by 7 percent – due to a drop in places such as France and Germany – even as countries in Eastern Europe such as Azerbaijan, Belarus and Russia The post increases. In Of AmericaThe case count fell 36 percent, with the United States – still the worst-affected country – reporting 1.87 million new cases, down 50 percent from the previous week.
The WHO cited limited data about the effectiveness of vaccines against omicron variants, while estimates showed the safety of the first series of COVID-19 vaccines against the variants for severe disease, symptomatic disease and infection to be low. Vaccines were most effective at preventing severe disease from Omicron.
The agency said the booster dose raises estimates of vaccine effectiveness by more than 75 percent for all vaccines for which data is available, although rates drop three to six months after injection.
,